BradleyRobertPrestidgeMDMS, FABS, FASTRO(He/Him)
Radiation Oncology • Spring, TXUrologic Cancer
Radiation Oncologist, Houston, TX
Dr. Prestidge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
24907 Delaney Knoll
Spring, TX 77389Phone+1 757-354-0458
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 1986 - 1989
David Grant Medical CenterInternship, Internal Medicine, 1985 - 1986
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 2011 - Present
IL State Medical License 2024 - 2026
OH State Medical License 2024 - 2026
CO State Medical License 2021 - 2025
KY State Medical License 2023 - 2025
MN State Medical License 2022 - 2025
TX State Medical License 1990 - 2025- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow American Brachytherapy Society, 2017
Clinical Trials
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
Publications & Presentations
PubMed
- 11 citationsEffect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinic...Jeff M Michalski, Kathryn A Winter, Bradley R Prestidge, Martin G Sanda, Mahul Amin
Journal of Clinical Oncology. 2023-08-20 - 5 citationsACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.Nicholas G Zaorsky, Timothy N Showalter, Gary A Ezzell, Paul L Nguyen, Dean G Assimos
Advances in Radiation Oncology. 2017-03-20 - 19 citationsACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.Brian J. Davis, Al V. Taira, Paul L. Nguyen, Dean G. Assimos, Anthony V. D'Amico
Brachytherapy. 2017-03-01
Press Mentions
Dr. Bradley Prestidge | 2019 Health Care Hero for Radiation OncologyMarch 1st, 2019
No Benefit Observed from Combined Irradiation in Intermediate-Risk Prostate CancerOctober 6th, 2016
ASTRO: Brachytherapy Enough for Mid-Risk Prostate CancerSeptember 30th, 2016
Professional Memberships
- Member
- Member
- Member
- Member
- American Brachytherapy SocietyChairman of the Board, President, Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
